A carregar...

Ceftazidime treatment in cystic fibrosis: resistant organisms in sputum and faeces.

Ceftazidime was used as the only intravenous agent for treating lower respiratory tract infections in patients with cystic fibrosis. The risks of inducing beta lactamases and conferring antibiotic resistance are high when monotherapy is used; so the emergence of resistant bacteria was studied prospe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dalzell, A M, Sunderland, D, Hart, C A, Heaf, D P
Formato: Artigo
Idioma:Inglês
Publicado em: 1991
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC463083/
https://ncbi.nlm.nih.gov/pubmed/1903896
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!